Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Justera Health Ltd C.VTAL

Alternate Symbol(s):  SCRSF

Justera Health Ltd. is a Canadian company focused on health and wellness. It offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Its Concierge Medical business provides discreet and personalized concierge healthcare services, including IV Vitamin Therapy. Its services include Screenpro Security, Justera Health Product, Naturevan, Juillet Wellness, and TRINITI Corporation. It is also specialized in providing efficient COVID-19 testing and same-day test results through its Canadian labs. It offers two convenient methods to test: in clinic testing or mobile at home testing. It is a distributor of TonyMoly skin care products in Canada. It provides a full-service wellness center, providing a range of beauty and wellness services.


CSE:VTAL - Post by User

Post by Smokey1958on Jan 18, 2022 8:47am
252 Views
Post# 34327634

Datametrex NR ON Cash

Datametrex NR ON Cash

Agree wholeheartedly with the sentiments expressed thus far and would only add that cash on hand is even more relevant to ScreenPro.

Datametrex has a clear vision and developments/contracts that will see it expand and generate significant revenues post covid (end of 2022???). SCRN, on the other hand, needs to, and I believe will, diversify to move beyond covid, even in the world of testing. Imho it will be important at some time in the future for them to chart their own course, independent of DM ....which I again believe they will do.

In the meantime covid testing revenues (profits) that must be increasing significantly, based on the Datametrex NR, will be the catalyst for this diversification. As Morningstar's Fair Value sp still sits at $.07 today and the shorterm to longterm moving averages are steady at BUY things are looking up if the sp could sustainably bust free of $.03.

GLTE!!!

<< Previous
Bullboard Posts
Next >>